Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial
对于初始无法切除的仅有肝转移的结直肠癌患者,采用化疗(双药或三药方案)联合RAS状态靶向治疗作为转化治疗。UNICANCER PRODIGE-14随机临床试验
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-021-01644-y
Ychou, Marc; Rivoire, Michel; Thezenas, Simon; Guimbaud, Rosine; Ghiringhelli, Francois; Mercier-Blas, Anne; Mineur, Laurent; Francois, Eric; Khemissa, Faiza; Chauvenet, Marion; Kianmanesh, Reza; Fonck, Marianne; Houyau, Philippe; Aparicio, Thomas; Galais, Marie-Pierre; Audemar, Franck; Assenat, Eric; Lopez-Crapez, Evelyne; Jouffroy, Claire; Adenis, Antoine; Adam, René; Bouché, Olivier